An eye on hepatitis C: a review
| Autor: | Romero Henrique Carvalho Bertrand, Adriana Leite Xavier Bertrand, Thais Mota Gomes, Adalgisa de Sousa Paiva Ferreira |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Drogas antivirais de ação direta
Eye Infections Viral Hepatite C/tratamento farmacológico Direct-acting antiviral drugs Antiviral Agents Hepatitis C eye diseases Interferon/therapeutic use Hepatitis C/drug therapy lcsh:Ophthalmology Hepatite C/complicações lcsh:RE1-994 Hepatitis C/ complications Risk Factors Ribavirin Humans Interferons Interferon/uso terapêutico |
| Zdroj: | Arquivos Brasileiros de Oftalmologia v.82 n.2 2019 Arquivos brasileiros de oftalmologia Conselho Brasileiro de Oftalmologia (CBO) instacron:CBO Arquivos Brasileiros de Oftalmologia, Vol 82, Iss 2, Pp 161-167 (2019) |
| ISSN: | 1678-2925 |
| Popis: | This review aims to caution ophthalmologists about the ocular consequences leading to the diagnosis of hepatitis C virus infection. In addition, in this context, the effects of old and new drugs are discussed in the ophthalmological setting. The importance of early diagnosis and the curative treatment of the disease has been reported in the national and international literature, demonstrating that its progression has important implications for daily clinical and surgical ophthalmological practice. Despite the scarcity of studies on new direct-acting antiviral drugs, fewer side effects of these drugs have been shown when compared with conventional interferon treatment with or without ribavirin. The ophthalmologist’s risk of becoming infected, as demonstrated by the presence of the virus in ocular structures, and the possibility of contamination, is also discussed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|